Uso de antipsicóticos em idosos com demência: riscos clínicos e dilemas éticos
RIAGE - Revista Ibero-Americana de Gerontologia · 30.06.2026 · 9 · e485
DOI: 10.61415/riage.485 ↗Kurz gefasst
Fachartikel in der Zeitschrift RIAGE - Revista Ibero-Americana de Gerontologia, online erschienen am 30.06.2026. Verfasst von Emanuela Maldonado und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dementia is one of the major public health concerns of the 21st century and is frequently associated with Behavioral and Psychological Symptoms of Dementia (BPSD), which occur in up to 90% of patients. Antipsychotics have been widely prescribed for symptom control, despite their clinically significant risk profile in this population. Through a systematic documentary analysis of national and international guidelines published between 2016 and 2025, this work critically examines the use of antipsychotics in older adults with dementia, organizing the evidence into five thematic axes: clinical indications, risks and adverse effects, reassessment and deprescribing, non-pharmacological interventions, and ethical implications. Guidelines consistently recommend reserving antipsychotics for situations of substantial severity and only after documented failure of non-pharmacological approaches. Atypical antipsychotics are preferred. Major risks include increased mortality, cerebrovascular events, sedation, extrapyramidal symptoms, and metabolic syndrome. All guidelines emphasize the use of the lowest effective dose, with periodic reassessment and deprescribing within four to twelve weeks. Prescribing antipsychotics raises complex ethical dilemmas, particularly regarding the autonomy of patients with impaired decision-making capacity and the balance between benefit and harm. Their use as chemical restraint in institutional settings is considered ethically unacceptable. Therapeutic decisions must be individualized, shared with patients, families, and caregivers, and grounded in updated scientific evidence. The urgent implementation of non-pharmacological strategies and structured deprescribing programs is strongly highlighted.
Zitieren
APA
Maldonado, E., Machado, I., Moreira, R. A., Gomes, H. J., Ferreira, A., Franco, J. M., Gomes, J. R., & Guimarães, M. (2026). Uso de antipsicóticos em idosos com demência: riscos clínicos e dilemas éticos. RIAGE - Revista Ibero-Americana de Gerontologia, 9, e485. https://doi.org/10.61415/riage.485
Vancouver
Maldonado E, Machado I, Moreira RA, Gomes HJ, Ferreira A, Franco JM, et al. Uso de antipsicóticos em idosos com demência: riscos clínicos e dilemas éticos. RIAGE - Revista Ibero-Americana de Gerontologia. 2026;9:e485. doi:10.61415/riage.485
BibTeX
@article{Maldonado2026,
author = {Maldonado, Emanuela and Machado, Inês and Moreira, Raquel Alves and Gomes, Helena João and Ferreira, António and Franco, Joana Meneses and Gomes, Joana Raposo and Guimarães, Manuel},
title = {Uso de antipsicóticos em idosos com demência: riscos clínicos e dilemas éticos},
journal = {RIAGE - Revista Ibero-Americana de Gerontologia},
year = {2026},
volume = {9},
pages = {e485},
doi = {10.61415/riage.485}
}
EUVIMED